Palforzia Approval Status
FDA Approved: No
Brand name: Palforzia
Generic name: peanut immunotherapy
Previous Name: AR101
Company: Aimmune Therapeutics, Inc.
Treatment for: Peanut Allergy
Palforzia (AR101) is an investigational biologic oral immunotherapy for desensitization of patients with peanut allergy.
Development Status and FDA Approval Process for Palforzia
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.